Vivek Dave, Raja Narayanan. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Angiogenesis Inhibitors/adverse effectsAngiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedBevacizumabChoroidal Neovascularization/drug therapyChoroidal Neovascularization/etiologyFluorescein AngiographyFovea Centralis/drug effectsHumansInjectionsMyopia, Degenerative/complicationsRandomized Controlled Trials as TopicRanibizumabTomography, Optical CoherenceTreatment OutcomeVascular Endothelial Growth Factor A/antagonists & inhibitorsVisual Acuity/drug effectsVitreous Body
Substances： See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedVascular Endothelial Growth Factor ABevacizumabRanibizumab
Year: 2010 PMID： 21036211 DOI： 10.1016/j.ajo.2010.07.005
Source DB: PubMed Journal: Am J Ophthalmol ISSN： 0002-9394 Impact factor: 5.258